113 results
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
16 Apr 24
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
9:31pm
Biosciences where he was responsible for defining the portfolio strategy and advancement of development plans toward regulatory approvals. He began his
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
16 Apr 24
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
9:31pm
positions of increasing responsibility. In her role as the Head of R&D strategy, she was responsible for characterizing the productivity of the portfolio … and driving key R&D strategy projects including the annual R&D Long-Range Plan. Additionally, she was Leader of Zyprexa Product Management in which she
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
9 Apr 24
BrainStorm Cell Therapeutics Announces Agreement with FDA on a
6:05am
provides the greatest benefit to companies in planning late-phase development strategy. A SPA agreement does not indicate FDA concurrence on every
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
20 Dec 23
BrainStorm Issues 2023 Letter to Shareholders
5:04pm
recognition for the unmet need in ALS and its willingness to reach alignment with Brainstorm on our new clinical strategy.
Our team is diligently preparing … listing status. Our strategy focuses on enhancing the value of our assets, thereby garnering market support that is crucial for our stock price to reach
8-K
EX-99.1
rbmgry157kly8t 8uc
14 Aug 23
BrainStorm Cell Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
7:21am
8-K
1zpfa9sc
11 Oct 22
BrainStorm Presents New Biomarker Analyses from NurOwn’s Phase 3 ALS Trial at the ALS ONE Research Symposium
8:01pm
8-K
EX-99.1
al06yzbm7ul5
15 Aug 22
BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update
7:22am
8-K
EX-99.1
rsi zo9j0gkbyi
28 Mar 22
BrainStorm Cell Therapeutics Announces Full Year 2021 Financial
7:15am
8-K
EX-99.2
wxwqbd iwo
28 Jan 22
BrainStorm Cell Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
4:10pm